HUMANA INC

HUM 10-K · Q4 2025
API behind this page

HUM Q4 2025 request

Playground key active
Request URL /api/financials?ticker=HUM&year=2025&quarter=4
waiting 0 ms 
Pick an endpoint and run the request.
curl

Income Statement

JSON CSV Excel
Income Statement
Metric Q4 2025 Q4 2024 YoY
Premiums Earned Net 30,884 27,750 +11.3%
Show Product Lines breakouts
Product 30,884 27,750 +11.3%
Product · Insurance 30,884 27,750 +11.3%
Revenue From Contract With Customer Including Assessed Tax 1,499 1,166 +28.6%
Show Product Lines breakouts
Service 1,499 1,166 +28.6%
Service · CenterWell 1,207 915 +31.9%
Service · Insurance 292 251 +16.3%
Investment Income Interest And Dividend 132 297 -55.6%
Revenue 32,515 29,213 +11.3%
Show Product Lines breakouts
External Revenues 32,383 28,916 +12.0%
External Revenues · CenterWell 1,207 915 +31.9%
External Revenues · Insurance 31,176 28,001 +11.3%
Show Business Segments breakouts
CenterWell · Eliminations/ Corporate 4,755 4,215 +12.8%
CenterWell · Operating Segments 5,962 5,130 +16.2%
Insurance · Eliminations/ Corporate 1 1 0.0%
Insurance · Operating Segments 31,343 28,170 +11.3%
Show Consolidation Items breakouts
Eliminations/ Corporate -4,790 -4,087 -17.2%
Intersegment Elimination -4,756 -4,216 -12.8%
Policyholder Benefits And Claims Incurred Net 28,721 25,381 +13.2%
Show Business Segments breakouts
Insurance · Operating Segments 28,765 25,547 +12.6%
Show Consolidation Items breakouts
Eliminations/ Corporate -44 -166 +73.5%
Selling, General & Administrative 4,438 4,167 +6.5%
Show Business Segments breakouts
CenterWell · Operating Segments 5,617 4,745 +18.4%
Insurance · Operating Segments 3,360 3,089 +8.8%
Show Consolidation Items breakouts
Eliminations/ Corporate -4,539 -3,667 -23.8%
Depreciation And Amortization 164 208 -21.2%
Show Business Segments breakouts
CenterWell · Operating Segments 47 58 -19.0%
Insurance · Operating Segments 145 180 -19.4%
Show Consolidation Items breakouts
Eliminations/ Corporate -28 -30 +6.7%
Benefits Losses And Expenses 33,323 29,756 +12.0%
Show Business Segments breakouts
CenterWell · Operating Segments 5,664 4,803 +17.9%
Insurance · Operating Segments 32,270 28,816 +12.0%
Show Consolidation Items breakouts
Eliminations/ Corporate -4,611 -3,863 -19.4%
Operating Income -808 -543 -48.8%
Show Business Segments breakouts
CenterWell · Operating Segments 298 327 -8.9%
Insurance · Operating Segments -927 -646 -43.5%
Show Consolidation Items breakouts
Eliminations/ Corporate -179 -224 +20.1%
Interest Expense 146 164 -11.0%
Other Non-Operating Income (Expense) 53 155 -65.8%
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments -1,011 -862 -17.3%
Income Tax Expense (Benefit) -249 -216 -15.3%
Income Loss From Equity Method Investments -14 -37 +62.2%
Net Income -776 -683 -13.6%
Show Equity Components breakouts
Noncontrolling Interest 20 10 +100.0%
Parent -796 -693 -14.9%
Retained Earnings -796 -693 -14.9%
Net Income Loss Attributable To Noncontrolling Interest -20 -10 -100.0%
Net Income -796 -693 -14.9%
EPS (Basic) -6.6 -5.75 -14.8%
EPS (Diluted) -6.59 -5.74 -14.8%
Comprehensive Income -763 -1,107 +31.1%
Other Comprehensive Income 33 -414 +108.0%
Wtd Avg Shares (Basic) -38 -38 0.0%
Wtd Avg Shares (Diluted) 48 -30 +260.0%
Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1 28,721 25,381 +13.2%

Balance Sheet

Balance Sheet
Metric Q4 2025 Q4 2024 YoY
Current Assets
Cash & Cash Equivalents 4,200 2,221 +89.1%
Show Consolidated Entities breakouts
Parent Company 1,328 329 +303.6%
Short-Term Investments 15,703 18,214 -13.8%
Show Consolidated Entities breakouts
Parent Company 215 233 -7.7%
Receivables Net Current 3,270 2,704 +20.9%
Show Consolidated Entities breakouts
Parent Company · Subsidiaries 3,342 2,874 +16.3%
Other Assets Current 9,560 6,676 +43.2%
Show Consolidated Entities breakouts
Parent Company 1,854 595 +211.6%
Total Current Assets 32,733 29,815 +9.8%
Show Consolidated Entities breakouts
Parent Company 6,739 4,031 +67.2%
Show Equity Method Investment Nonconsolidated Investee breakouts
Gentiva Hospice 430 407 +5.7%
Accounts Receivable (Q) — — —
Show Product Lines breakouts
Service 367 360 +1.9%
Non-Current Assets
Property, Plant & Equipment 2,231 2,532 -11.9%
Show Consolidated Entities breakouts
Parent Company 1,653 1,876 -11.9%
Available For Sale Securities Debt Securities Noncurrent 493 421 +17.1%
Goodwill 9,686 9,631 +0.6%
Show Business Segments breakouts
CenterWell 7,023 6,968 +0.8%
Insurance 2,663 2,663 0.0%
Show Reporting Unit breakouts
Home Solutions Reporting Unit 4.4 — —
Other Non-Current Assets 3,128 3,383 -7.5%
Show Consolidated Entities breakouts
Parent Company 944 364 +159.3%
Total Assets 48,909 46,479 +5.2%
Show Consolidated Entities breakouts
Parent Company 40,852 37,282 +9.6%
Operating Lease Right-of-Use Assets 485 445 +9.0%
Intangible Assets (Q) — — —
Show Finite Lived Intangible Assets By Major Class breakouts
Contractual Rights 2 3 -33.3%
Customer Contracts 40 206 -80.6%
Noncompetes and other 27 34 -20.6%
Trade Names 7 20 -65.0%
Other Assets
Equity Method Investments 638 697 -8.5%
Current Liabilities
Liability For Claims And Claims Adjustment Expense 9,967 10,440 -4.5%
Accounts Payable And Accrued Liabilities Current 5,717 5,259 +8.7%
Book Overdraft Liability 306 403 -24.1%
Show Consolidated Entities breakouts
Parent Company 43 70 -38.6%
Deferred Revenue (Current) 356 260 +36.9%
Total Current Liabilities 16,346 16,939 -3.5%
Show Consolidated Entities breakouts
Parent Company 10,402 9,392 +10.8%
Show Equity Method Investment Nonconsolidated Investee breakouts
Gentiva Hospice 327 413 -20.8%
Accounts Payable (Q) — — —
Show Consolidated Entities breakouts
Parent Company · Subsidiaries 7,505 7,144 +5.1%
Non-Current Liabilities
Long-Term Debt 12,369 11,144 +11.0%
Show Debt Instrument breakouts
$1,000 million, 5.750% due April, 15, 2054 · Senior Notes 991 972 +2.0%
$1,500 million, 5.375% due April, 15, 2031 · Senior Notes 1,493 1,226 +21.8%
$250 million, 8.150% due June 15, 2038 · Senior Notes 260 260 0.0%
$400 million, 4.625% due December 1, 2042 · Senior Notes 374 366 +2.2%
$400 million, 4.800% due March 15, 2047 · Senior Notes 396 392 +1.0%
$500 million, 3.125% due August 15, 2029 · Senior Notes 388 433 -10.4%
$500 million, 3.950% due August 15, 2049 · Senior Notes 517 505 +2.4%
$500 million, 4.875% due April 1, 2030 · Senior Notes 497 497 0.0%
$500 million, 5.750% due December 1, 2028 · Senior Notes 497 496 +0.2%
$500 million, 5.750% due March 1, 2028 · Senior Notes 491 490 +0.2%
$500 million, 6.000% due May 1, 2055 · Senior Notes 486 — —
$600 million, 3.950% due March 15, 2027 · Senior Notes 466 538 -13.4%
$750 million, 1.350% due February 3, 2027 · Senior Notes 563 689 -18.3%
$750 million, 2.150% due February 3, 2032 · Senior Notes 592 744 -20.4%
$750 million, 3.700% due March 23, 2029 · Senior Notes 586 585 +0.2%
$750 million, 4.950% due October 1, 2044 · Senior Notes 717 714 +0.4%
$750 million, 5.500% due March 15, 2053 · Senior Notes 727 705 +3.1%
$750 million, 5.550% due May 1, 2035 · Senior Notes 746 — —
$750 million, 5.875% due March 1, 2033 · Senior Notes 750 726 +3.3%
$850 million, 5.950% due March 15, 2034 · Senior Notes 832 806 +3.2%
Show Consolidated Entities breakouts
Parent Company 12,369 11,144 +11.0%
Other Non-Current Liabilities 2,457 1,951 +25.9%
Show Consolidated Entities breakouts
Parent Company 424 371 +14.3%
Total Liabilities 31,172 30,034 +3.8%
Show Consolidated Entities breakouts
Parent Company 23,195 20,907 +10.9%
Operating Lease Liabilities 418 392 +6.6%
Stockholders' Equity
Common Stock 33 33 0.0%
Show Consolidated Entities breakouts
Parent Company 33 33 0.0%
Additional Paid In Capital Common Stock 3,600 3,463 +4.0%
Show Consolidated Entities breakouts
Parent Company 3,600 3,463 +4.0%
Retained Earnings 29,075 28,317 +2.7%
Show Consolidated Entities breakouts
Parent Company 29,075 28,317 +2.7%
Accumulated Other Comprehensive Income -633 -1,067 +40.7%
Show Consolidated Entities breakouts
Parent Company -633 -1,067 +40.7%
Treasury Stock Common Value -14,418 -14,371 -0.3%
Show Consolidated Entities breakouts
Parent Company -14,418 -14,371 -0.3%
Total Stockholders' Equity 17,657 16,375 +7.8%
Show Consolidated Entities breakouts
Parent Company 17,657 16,375 +7.8%
Show Equity Method Investment Nonconsolidated Investee breakouts
Gentiva Hospice 1,335 1,468 -9.1%
Minority Interest 80 70 +14.3%
Stockholders Equity Including Portion Attributable To Noncontrolling Interest 17,737 16,445 +7.9%
Show Equity Components breakouts
Accumulated Other Comprehensive Income -633 -1,067 +40.7%
Additional Paid In Capital 3,600 3,463 +4.0%
Common Stock 33 33 0.0%
Noncontrolling Interest 80 70 +14.3%
Parent 17,657 16,375 +7.8%
Retained Earnings 29,075 28,317 +2.7%
Treasury Stock Common -14,418 -14,371 -0.3%
Total Liabilities & Equity 48,909 46,479 +5.2%
Show Consolidated Entities breakouts
Parent Company 40,852 37,282 +9.6%

Cash Flow Statement

Cash Flow Statement
Metric YTD Q4 2025 YTD Q4 2024 YoY
Operating Activities
Stock-Based Compensation 48 54 -11.1%
Change in Deferred Revenue 91 65 +40.0%
Net Cash from Operations -1,652 -528 -212.9%
Investing Activities
Capital Expenditures -202 -154 -31.2%
Purchases of Investments -1,242 -2,143 +42.0%
Net Cash from Investing 632 -63 +1103.2%
Financing Activities
Share Repurchases -42 -49 +14.3%
Debt Issuance Costs 0 0 —
Net Cash from Financing -168 -2,304 +92.7%
Supplemental
Interest Paid 188 168 +11.9%
Other Cash Flow
Net Change in Cash -1,188 -2,895 +59.0%

Values in millions USD. Source: SEC EDGAR 10-K filing.

This table is rendered from the same JSON returned by /api/financials.

Get API Key